Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients Clinical research trials and Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients. Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients clinical trial. Test subjects typically receive the most effective healthcare possible for their Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients

Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients



Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients

For Condition: Congestive Heart Failure
Status: Completed
Sponsor(s): Otsuka Maryland Research Institute ,
Synopsis: Patients with congestive heart failure will be assessed for safety and clinical effects of Tolvaptan 30 mg every day versus 15 mg twice a day over a period of 7 days.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Pharmacokinetics/Dynamics Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: History of CHF
Total Enrollment: 40

Location and Contact Information:

University of Missouri-Kansas City School of Medicine
Kansas City,  Missouri, 
United States
 

University of Miami/Jackson Memorial Hospital
Miami,  Florida, 
United States
 

Central Cardiology Medical Clinic
Bakersfield,  California, 
United States
 

Saint Louis University
St. Louis,  Missouri, 
United States
 

Medical University of South Carolina
Charleston,  South Carolina, 
United States
 

Androscoggin Cardiology Associates
Auburn,  Maine, 
United States
 

University of California-San Diego
San Diego,  California, 
United States
 

Cardiology of Oklahoma
Tulsa,  Oklahoma, 
United States
 

Medical Research Institute
Slidell,  Louisiana, 
United States
 

University of Miami/Jackson Memorial Hospital
Miami,  Florida, 
United States
 


Additional Information:
Study ID Numbers:
  156-01-231; 
Study Start Date: May 2002
Record last reviewed: September 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00043771

Other Congestive Heart Failure Studies:
1. MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)

2. Autologous Cultured Myoblasts (BioWhittaker) Transplanted via Myocardial Injection

3. Eplerenone on Cardiac Remodeling in Patients with Left Ventricular Systolic Dysfunction and Mild to Moderate Heart Failure

4. African-American Heart Failure Trial

5. Trial of a Tailored Message Program to Implement CHF Guidelines

Related Studies:

Other Congestive Heart Failure Clinical Trials
Other Louisiana Clinical Trials
Other Slidell Clinical Trials

Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients

Modify your Search

  Other Congestive Heart Failure Clinical Trials
  Other Louisiana Clinical Trials
  Other Slidell Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103